Admit Therapeutics
ADmit Therapeutics is biotech company focused on the commerzalitation of the MAP-AD Test, the first epigenetic IVD Test for the prognosis of Alzheimer’s disease
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
14
1 to 10 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
3
tools in use
Monthly traffic
75
organic / mo
Sign up free to see all 5 verified contacts at Admit Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
- CT
Carla Trapero
Project Manager · Science
EmailPhone - VF
Víctor Fuentes
Quality Manager · Other
EmailPhone
Showing 2 of 5 verified contacts
Top roles at Admit Therapeutics
5 distinct titles indexed · top 5 shown.
- 1bioinformático
- 1date entry clerk
- 1head of assay development
- 1project manager
- 1quality manager
Sign up to unlock all 5 contacts at Admit Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Admit Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.